Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts


  HIV Infection

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 346 articles:
HTML format



Single Articles


    May 2025
  1. BUSZA J, Machingura F, Kujeke T, Makamba M, et al
    What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes.
    AIDS. 2025;39:771-773.
    PubMed    


  2. HATCHER AM, Metheny N, Dunkle KL, Fielding-Miller R, et al
    A refusal to abandon HIV science.
    AIDS. 2025;39:768-770.
    PubMed    


  3. MELDRUM BG, McGee-Avila JK, Luo Q, Milan J Jr, et al
    Racial disparities in cancer risk among MSM with HIV in the United States.
    AIDS. 2025;39:728-736.
    PubMed     Abstract available


  4. PARCZEWSKI M, Boesecke C, Khaykin P, Jilich D, et al
    Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response.
    AIDS. 2025;39:629-638.
    PubMed     Abstract available


    April 2025
  5. OH TK, Song KH, Heo E, Song IA, et al
    Association between HIV and cancer risk: a nationwide, population-based cohort study.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004210.
    PubMed     Abstract available


  6. NAMPOTA-NKOMBA N, Mohanty K, Adebiyi R, Ekeh C, et al
    Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIV.
    AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004209.
    PubMed     Abstract available


  7. BOUWMEESTER TA, van der Wulp IAJ, Kusi Mensah YA, Wit FWNM, et al
    Impaired autonomic cardiovascular control in people with HIV on long-term successful treatment.
    AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004208.
    PubMed     Abstract available


  8. DUARTE HA, Birnbaum JK, Carlucci JG, Ghazal Y, et al
    Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya.
    AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004207.
    PubMed     Abstract available


  9. LI Y, Soto-Ramirez ZN, Roscher J, Medvec T, et al
    Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004204.
    PubMed     Abstract available


  10. VAN DER MANNEN JS, Furamera S, Pienaar J, Komane P, et al
    Predictors of unsuppressed viral load among men who have sex with men living with HIV in South Africa.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004205.
    PubMed     Abstract available


  11. WANG L, Li SM, Li X, Wu HS, et al
    The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late events of viral nuclear import.
    AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004206.
    PubMed     Abstract available


  12. GLENN JS, Bennett A, Mackie N, Lyall H, et al
    The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
    PubMed     Abstract available


  13. BENZEKRI NA, Plaisy MK, Koffi JJ, Mensah E, et al
    Food insecurity and mental health outcomes among people living with HIV in West Africa.
    AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004200.
    PubMed     Abstract available


  14. MOLLAN KR, Pence BW, Westreich D, Bula A, et al
    Effectiveness of levonorgestrel implant and depot medroxyprogesterone acetate injectable for women living with HIV on efavirenz: a prospective cohort study.
    AIDS. 2025 Apr 3. doi: 10.1097/QAD.0000000000004201.
    PubMed     Abstract available


  15. SHAH S, Short CE, Taylor G, Lyall H, et al
    Comparison of pregnancy outcomes between people with perinatally acquired HIV, horizontally acquired HIV and those without HIV.
    AIDS. 2025;39:621-624.
    PubMed     Abstract available


  16. RAMASWAMI R, Kelesidis T, Goedert JJ
    When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman disease among people with HIV.
    AIDS. 2025;39:618-620.
    PubMed    


  17. SAMAHA J, Madhu S, Shehadeh LA, Martinez CA, et al
    Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions.
    AIDS. 2025;39:483-495.
    PubMed     Abstract available


  18. RIOS-VAZQUEZ V, Vos WAJW, Blaauw MJT, Van Eekeren LE, et al
    Dolutegravir plus lamivudine downregulates cellular stress responses versus three-drug HIV Regimens.
    AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004198.
    PubMed     Abstract available


  19. YANG GW, Zhou QW, Zhen X, Yang Y, et al
    A promising prognostic model for patients with AIDS-related lymphoma in the cART era.
    AIDS. 2025 Apr 1. doi: 10.1097/QAD.0000000000004197.
    PubMed     Abstract available


    March 2025
  20. LIN LY, Ferte T, Chachage M, Casteano C, et al
    Deciphering HIV vaccine-induced Antibody response according to ethnicity.
    AIDS. 2025 Mar 31. doi: 10.1097/QAD.0000000000004196.
    PubMed     Abstract available


  21. KAMITANI E, DeLuca JB, Mizuno Y
    Systematic review of infodemiology studies using artificial intelligence: social media posts on HIV pre-exposure prophylaxis.
    AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004193.
    PubMed     Abstract available


  22. MARTINSON T, Heise MJ, Sassaman K, Schmidt HR, et al
    Interest and disparities in awareness and uptake of doxyPEP among U.S. MSM living with HIV.
    AIDS. 2025 Mar 27. doi: 10.1097/QAD.0000000000004192.
    PubMed     Abstract available


  23. DUARTE MJ, Tien PC, Kardashian A, Ma Y, et al
    Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
    AIDS. 2025 Mar 25. doi: 10.1097/QAD.0000000000004189.
    PubMed     Abstract available


  24. ZHANG L, Chen N, Wang X, Du J, et al
    Increased frequency of Foxp3+CD8+ T cells are associated with disease progression during HIV infection.
    AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004185.
    PubMed     Abstract available


  25. REIS K, Stephano PF, Fadhil S, Willkens M, et al
    Arterial stiffness in people with HIV: a cross-sectional, comparative study with echocardiographic outcomes in Tanzania.
    AIDS. 2025 Mar 20. doi: 10.1097/QAD.0000000000004184.
    PubMed     Abstract available


  26. ANDERSON K, Eley BS, Rabie H, Muloiwa R, et al
    Hospitalisation incidence among young children living with HIV in the Western Cape, South Africa.
    AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004156.
    PubMed     Abstract available


  27. BEYDOUN N, Nance RM, Durstenfeld MS, Hoffmann AP, et al
    Multicenter study of heart failure phenotypes and physician-adjudicated etiologies in people with HIV.
    AIDS. 2025 Mar 18. doi: 10.1097/QAD.0000000000004182.
    PubMed     Abstract available


  28. SORENSEN EF, Hybel TE, Ludvigsen M
    Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'.
    AIDS. 2025;39:481.
    PubMed    


  29. DAUNGSUPAWONG H, Wiwanitkit V
    Characterization of the genomic landscape of HIV-associated lymphoma.
    AIDS. 2025;39:480.
    PubMed    


  30. BELLOMO M, Gianotti N, Hasson H, Canetti D, et al
    Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens.
    AIDS. 2025;39:477-479.
    PubMed     Abstract available


  31. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
    People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
    AIDS. 2025;39:475-476.
    PubMed     Abstract available


  32. BABALOLA CM, Peters RPH, Muzny CA, Davey DJ, et al
    From pregnancy to beyond: renewed emphasis on comprehensive HIV prevention in South Africa.
    AIDS. 2025;39:470-474.
    PubMed     Abstract available


  33. GOODKIN K
    Sleep in the context of neuropsychiatric and primary medical comorbidity patterns among people with HIV.
    AIDS. 2025;39:467-469.
    PubMed    


  34. COHN SE
    Women with HIV: increased need for reproductive health services to improve health outcomes.
    AIDS. 2025;39:464-466.
    PubMed    


  35. BARBER TJ, Gonzalez-Scarano F, Vance DE
    Cognitive dysfunction in people with HIV: the potential effect of personal and environmental circumstances.
    AIDS. 2025;39:462-463.
    PubMed    


  36. SHORT WR, Rakhmanina N
    Expanding choices of antiretroviral treatment regimens for pregnant and breastfeeding persons with HIV.
    AIDS. 2025;39:459-461.
    PubMed    


  37. KUHN L, Thomas P
    Studies of young adults with perinatal HIV infection provide new clues for HIV cure.
    AIDS. 2025;39:457-458.
    PubMed    


  38. LUCEY M, Burns F, Bhagani S, Lipman M, et al
    SARS-CoV-2 antibody prevalence in adults living with HIV.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004180.
    PubMed     Abstract available


  39. KONSTANTINIDIS I, Papageorgiou SN, Zou RH, Ronit A, et al
    Effect of HIV on respiratory symptoms, health status, and exertional capacity: a systematic review and meta-analysis.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004179.
    PubMed     Abstract available


  40. DAO TTD, Filipowicz TR, Edmonds A, Ramirez C, et al
    Depressive symptoms among women of reproductive age with and without HIV in the Southern United States: baseline description from the STAR cohort.
    AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004181.
    PubMed     Abstract available


  41. IZQUIERDO R, Rava M, Gutierrez F, Garcia-Fraile LJ, et al
    Increased mortality and morbidity risk in people with early HIV care interruption in Spain, 2004-2023.
    AIDS. 2025 Mar 10. doi: 10.1097/QAD.0000000000004175.
    PubMed     Abstract available


  42. MAZZITELLI M, Krankowska D, Cozzolino C, Scaglione V, et al
    Sexual health knowledge, interest and acceptability of PrEP in migrant women: the MIMOSA study.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004174.
    PubMed     Abstract available


  43. LIEBZEIT CJ, Deng HY, Liang B, Li L, et al
    Unique expression of genes influencing transendothelial leukocyte migration in HIV-1 resistant women in the pumwani sex worker cohort.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004177.
    PubMed     Abstract available


  44. SCHMIDT HR, Heise MJ, Sassaman K, D'Angelo A, et al
    High viral suppression amid demographic disparities: a U.S. national cohort of people with HIV on a popular dating app.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004173.
    PubMed     Abstract available


  45. INZAULE S, Jordan MR, Fokam J, Hamers RL, et al
    Non-canonical HIV drug resistance mutations: need to close existing gaps.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004170.
    PubMed     Abstract available


  46. MUNK K, Suarez-Zdunek MA, Krabek R, Hamm SR, et al
    Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004172.
    PubMed     Abstract available


  47. JORDANS CCE, Vliegenthart-Jongbloed K, Osbak KK, Hanssen JLJ, et al
    Implementing HIV teams sustainably improves HIV indicator condition testing rates in hospitals in the Netherlands: the #aware.hiv clinical trial.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004167.
    PubMed     Abstract available


  48. PIGGOTT DA, Mehta SH, Rubin LH, Sun J, et al
    Cognitive function and mortality among persons aging with HIV and injection drug use.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004169.
    PubMed     Abstract available


  49. OLIVEIRA VH, Willig AL, Davey CH, Buford TW, et al
    Abdominal adiposity is negatively associated with physical function among people with HIV.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004168.
    PubMed     Abstract available


  50. MOYLE G, Gruber J, Dunbar M, Radtchenko J, et al
    Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption.
    AIDS. 2025 Mar 4. doi: 10.1097/QAD.0000000000004171.
    PubMed     Abstract available


  51. CASPER SJ, Fix ML, Spivak AM
    A blind spot in HIV diagnosis guidelines?
    AIDS. 2025;39:334-335.
    PubMed    


  52. ZHEN XM, Liu ZH, Zhang L, Xiao F, et al
    Epstein-Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS.
    AIDS. 2025;39:330-333.
    PubMed     Abstract available


  53. MARZIALI ME, Kooij KW, Zhang W, Budu M, et al
    Fatal overdoses among people with HIV experiencing nonfatal overdoses in British Columbia, Canada.
    AIDS. 2025;39:328-330.
    PubMed     Abstract available


  54. TAO J, Maguire-Wilkerson A, Rusley J, Wray T, et al
    Implementing conversational artificial intelligence technology for the prevention of HIV and other sexually transmitted infections in real-world settings.
    AIDS. 2025;39:324-327.
    PubMed    


  55. GOODKIN K, Pollack HA
    Contextual factors related to the overlap of the overdose and HIV pandemics and their clinical implications.
    AIDS. 2025;39:321-323.
    PubMed    


  56. NGENO GTK, Bloomfield GS
    Global health solidarity in the HIV and hypertension disease response.
    AIDS. 2025;39:319-320.
    PubMed    


  57. BRENNER BG, Fairlie L
    The need to avert emergent resistance to dolutegravir in children and adolescents with HIV.
    AIDS. 2025;39:317-318.
    PubMed    


  58. BENNETT T, Walmsley S, Bendayan R
    Aging with HIV and HIV-associated neurocognitive impairment.
    AIDS. 2025;39:215-228.
    PubMed     Abstract available


    February 2025
  59. NAJJUUKO C, Brathwaite R, Xu Z, Kizito S, et al
    Using machine learning to predict poor adherence to antiretroviral therapy among adolescents living with HIV in low resource settings.
    AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004163.
    PubMed     Abstract available


  60. WHELTON SP, Haberlen SA, Zhang L, Herrschaft R, et al
    Associations between HIV serostatus and coronary artery plaque volume progression.
    AIDS. 2025 Feb 25. doi: 10.1097/QAD.0000000000004165.
    PubMed     Abstract available


  61. TAM C, Zhang W, Moore D, Salters K, et al
    Impacts of overdose and socio-structural factors on recent mortality among people living with HIV in British Columbia, Canada.
    AIDS. 2025 Feb 24. doi: 10.1097/QAD.0000000000004158.
    PubMed     Abstract available


  62. CHALOUNI M, Van Santen DK, Berenguer J, Jarrin I, et al
    Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus.
    AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004161.
    PubMed     Abstract available


  63. LI W, Egler A, Oyungu E, Yang Z, et al
    Pro- and anti-inflammatory immune biomarkers as predictors of neurodevelopment in young children exposed to HIV.
    AIDS. 2025 Feb 19. doi: 10.1097/QAD.0000000000004162.
    PubMed     Abstract available


  64. NUHN MM, Bosman K, Huisman T, Staring WHA, et al
    Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets.
    AIDS. 2025 Feb 17. doi: 10.1097/QAD.0000000000004160.
    PubMed     Abstract available


  65. VAN PAASSEN PM, Boyd AC, Pasternak AO, Maurer I, et al
    Soluble CD14 and IL-12p70 on early ART predict HIV load setpoint after treatment interruption.
    AIDS. 2025 Feb 14. doi: 10.1097/QAD.0000000000004159.
    PubMed     Abstract available


  66. FILIP I
    Transplantation of kidneys from donors with HIV: are we there yet?
    AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004155.
    PubMed    


  67. SHEIRA LA, Kwena ZA, Ayieko B, Charlebois ED, et al
    The effect of a social network-based intervention on adherence to HIV pre-exposure prophylaxis and HIV viral suppression among Kenyan fishermen.
    AIDS. 2025 Feb 13. doi: 10.1097/QAD.0000000000004157.
    PubMed     Abstract available


  68. RAMI A, Pozniak AL, Assoumou L, Movahedi R, et al
    Use of doravirine-based regimens in clinical practice in Europe: a real-life retrospective observational study.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004151.
    PubMed     Abstract available


  69. HERLIHY JM, Zulu E, Mwananyanda L, Forman L, et al
    Risk of hospitalization or death does not differ in children exposed to HIV, yet uninfected compared to non-exposed peers in the Zambia Infant Cohort Study (ZICS).
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004152.
    PubMed     Abstract available


  70. BALDIN G, Salvo PF, Passerotto RA, Iannone V, et al
    'With age comes wisdom': effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004153.
    PubMed     Abstract available


  71. VOLESKY-AVELLANEDA KD, Luo Q, Amaswami RR, Lurain K, et al
    Primary effusion lymphoma in people with and without HIV infection in the United States.
    AIDS. 2025 Feb 12. doi: 10.1097/QAD.0000000000004154.
    PubMed     Abstract available


  72. AGBEY C, Walton S, Campbell LA, Nath A, et al
    Expression of human immunodeficiency virus envelope protein in the human central nervous system.
    AIDS. 2025 Feb 11. doi: 10.1097/QAD.0000000000004150.
    PubMed     Abstract available


  73. MATOVU KIWEEWA F, Stranix-Chibanda L, Yende-Zuma N, Dadabhai S, et al
    Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa.
    AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004148.
    PubMed     Abstract available


  74. KNOX J, Magana C, Duncan DT, Shrader CH, et al
    Cannabis use and HIV among Black sexually minoritized men: a systematic review and narrative analysis.
    AIDS. 2025 Feb 7. doi: 10.1097/QAD.0000000000004149.
    PubMed     Abstract available


  75. MARSEILLE E, Walker RS, Hickey MD, Grochowski J, et al
    Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004145.
    PubMed     Abstract available


  76. OGBUAGU OE, Avihingsanon A, Segal-Maurer S, Wang H, et al
    Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004142.
    PubMed     Abstract available


  77. HICKS S, Jiang W, Kibugi J, Badia J, et al
    Sociobehavioral determinants of non-retention among adolescents and young adults living with HIV.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004141.
    PubMed     Abstract available


  78. VIGUERIE A, O'Shea J, Johnston M, Schreiber D, et al
    Impact of increased uptake of long-acting injectable antiretroviral therapy on HIV incidence and viral suppression in the United States under 2021 FDA guidelines.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004144.
    PubMed     Abstract available


  79. JACKSON C, Crichton S, Judd A, Bamford A, et al
    Long-term non-progression in children living with HIV: estimates from international cohort data.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004136.
    PubMed     Abstract available


  80. JEENA L, Ferrand RA, Simms V, Kahari C, et al
    Reduced peri-pubertal bone density accrual among Zimbabwean males living with HIV: a longitudinal study.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004134.
    PubMed     Abstract available


  81. DIAZ MM, Kamalyan L, Al-Rousan T, Breton J, et al
    Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among U.S. Latinos living with HIV.
    AIDS. 2025 Feb 5. doi: 10.1097/QAD.0000000000004143.
    PubMed     Abstract available


  82. SCOFIELD D, Frisch M, Andersson M, Storgaard M, et al
    Physical, psychosocial and sexual health among people aged 50 years and above with and without HIV: a nationwide study.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004140.
    PubMed     Abstract available


  83. WAGNER T, Levy I, Wieder-Finesod A, Wax M, et al
    Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in Israel.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004138.
    PubMed     Abstract available


  84. DIEZ-VIDAL A, Gil-Garrote S, Diaz-Pollan B, Rodriguez-Sevilla G, et al
    Amebic liver abscess presenting in a nonendemic region after a 12-year latency in a patient with well controlled HIV infection.
    AIDS. 2025;39:211-213.
    PubMed    


  85. BOWLER SA, Premeaux TA, Ratzan L, Friday C, et al
    Plasma anti-CD4 IgG levels are associated with poor immune recovery in people with HIV initiating antiretroviral therapy.
    AIDS. 2025;39:208-210.
    PubMed     Abstract available


  86. GONZALEZ-SCARANO F, Kolson DL
    Imaging brain inflammation in virally suppressed people with HIV-1.
    AIDS. 2025;39:204-205.
    PubMed    


    January 2025
  87. NAIDU N, Kooij KW, Budu M, Ye M, et al
    Exploring the role of sex in hospitalizations among people with and without HIV in British Columbia, Canada.
    AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004135.
    PubMed     Abstract available


  88. BROWN MJ, Murtala NM, Amoatika D, Kaur A, et al
    Clinical and sociodemographic characteristics of alzheimer's disease and related dementias (AD/ADRD) among people living with HIV: a cross-sectional analysis.
    AIDS. 2025 Jan 31. doi: 10.1097/QAD.0000000000004137.
    PubMed     Abstract available


  89. SPENCER M, Pieri C, Hamzah L, Popoola J, et al
    Antiretroviral therapy in people with HIV and end-stage kidney disease.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004128.
    PubMed     Abstract available


  90. URBINA EM, Yu W, Williams PL, Sawyer G, et al
    Central arterial stiffness in young adults with perinatal HIV exposure & infection.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004129.
    PubMed     Abstract available


  91. HANTTU AM, Muniandy M, van der Kolk BW, Lindgren H, et al
    Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004131.
    PubMed     Abstract available


  92. XIE X, Fu Y, Gan L, Yang X, et al
    Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study.
    AIDS. 2025 Jan 27. doi: 10.1097/QAD.0000000000004130.
    PubMed     Abstract available


  93. BLEICHRODT AM, Okano JT, Fung IC, Chowell G, et al
    The Future of HIV: Challenges in meeting the 2030 Ending the HIV Epidemic in the U.S. (EHE) reduction goal.
    AIDS. 2025 Jan 17. doi: 10.1097/QAD.0000000000004122.
    PubMed     Abstract available


  94. BRANTON WG, Zhang N, Cohen EA, Brew BJ, et al
    Brain RNA profiling highlights multiple disease pathways in persons with HAND: uncovering determinants of biotype diversity.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004116.
    PubMed     Abstract available


  95. PANG X, Ma J, He Q, Tang K, et al
    Analysis of HIV transmission characteristics and intervention effects in Guangxi based on molecular networks.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004123.
    PubMed     Abstract available


  96. PATEL VV, Andrade EA, Zimba R, Mirzayi C, et al
    Preferences for HIV PrEP care among gay, bisexual, and other men who have sex with men: a large discrete choice experiment.
    AIDS. 2025 Jan 16. doi: 10.1097/QAD.0000000000004124.
    PubMed     Abstract available


  97. LUCKETT R, Ramogola-Masire D, Zash R, Sears E, et al
    Cervical dysplasia in women with HIV in the modern treat-all era: Elevated risk remains despite long-term ART and normal CD4 count.
    AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004120.
    PubMed     Abstract available


  98. DOLLFUS C, Chenadec JL, Reliquet V, Alby-Laurent F, et al
    Outcomes and challenges in adolescents living with HIV in France: a nationwide cohort study over 35 years (1985-2020).
    AIDS. 2025 Jan 13. doi: 10.1097/QAD.0000000000004121.
    PubMed     Abstract available


  99. POURCHER V, Robineau O, Parienti JJ, Loubet P, et al
    Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France.
    AIDS. 2025 Jan 10. doi: 10.1097/QAD.0000000000004118.
    PubMed     Abstract available


  100. TAVASOLI A, Okwuegbuna OK, Tang B, Iudicello JE, et al
    Hepcidin modifies the relationship between anemia, erythrocyte indices, and neurocognitive performance in virally suppressed people with HIV.
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004110.
    PubMed     Abstract available


  101. HIDALGO-TENORIO C, Calle-Gomez I, Moya R, Omar M, et al
    Prevalence and incidence of HPV-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people living with HIV (PLHIV).
    AIDS. 2025 Jan 7. doi: 10.1097/QAD.0000000000004113.
    PubMed     Abstract available


  102. CASSIDY AR, Mayondi G, Williams PL, Moabi K, et al
    Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based ART.
    AIDS. 2025 Jan 6. doi: 10.1097/QAD.0000000000004111.
    PubMed     Abstract available


  103. VYAS KJ, Marconi VC, Agan BK, Sullivan PS, et al
    Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004105.
    PubMed     Abstract available


  104. BOERING P, Murray C, Portwood C, Hey M, et al
    Perinatal outcomes among pregnant women living with HIV initiating antiretroviral therapy preconception and antenatally: systematic review and meta-analysis.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004104.
    PubMed     Abstract available


  105. MULINGE MM, Kimani H, Inziani M, Bwana P, et al
    Trends and factors associated with HIV viral load non-suppression among treatment-experienced female sex workers in Kenya: a retrospective cohort study.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004102.
    PubMed     Abstract available


  106. WILLIAMS ME, Asia LK, Lindeque Z, Van Vuren EJ, et al
    The relationship between immune markers and tryptophan-kynurenine metabolites in South African people with HIV.
    AIDS. 2025 Jan 3. doi: 10.1097/QAD.0000000000004103.
    PubMed     Abstract available



  107. The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV: Erratum.
    AIDS. 2025;39:103.
    PubMed    


  108. DO NASCIMENTO AAA, Pasqualotto AC
    Fungal diseases are not in the radar of main international HIV conferences.
    AIDS. 2025;39:99-100.
    PubMed    


  109. ALAGARATNAM J, Kelly N, Dustan S, Naous N, et al
    Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine.
    AIDS. 2025;39:95-98.
    PubMed     Abstract available


  110. FUNDERBURG N
    Food insecurity likely contributes to frailty in people with HIV.
    AIDS. 2025;39:93-94.
    PubMed    


  111. GUARALDI G, Winslow DL, Raggi P
    REPRIEVE informs on kidney disease in people with HIV.
    AIDS. 2025;39:91-92.
    PubMed    


  112. BRUGUERA A, Nomah DK, Moreno-Fornes S, Martinez E, et al
    Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands.
    AIDS. 2025;39:64-74.
    PubMed     Abstract available


  113. BONACINA S, Lichtenstein JD, Niemczak CE, Magohe A, et al
    The relationship between HIV and reading performance for children in Tanzania.
    AIDS. 2025;39:49-56.
    PubMed     Abstract available


  114. VANPOUILLE C, Wells A, DeGruttola V, Lynch M, et al
    Cytokine trajectory over time in men and women with HIV on long-term antiretroviral therapy.
    AIDS. 2025;39:1-10.
    PubMed     Abstract available


    December 2024
  115. BILLOCK RM, France AM, Saduvala N, Panneer N, et al
    Contribution of HIV transmission bursts to future HIV infections, United States.
    AIDS. 2024 Dec 24. doi: 10.1097/QAD.0000000000004101.
    PubMed     Abstract available


  116. VAN ZYL GU, Jennings L, Rabie H, Orrell C, et al
    Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success.
    AIDS. 2024 Dec 23. doi: 10.1097/QAD.0000000000004099.
    PubMed    


  117. RUDERMAN SA, Nance RM, Crane HM, Cachay E, et al
    Cumulative HIV viral load and lower CD4 cell count are associated with incident venous thromboembolism in people with HIV.
    AIDS. 2024 Dec 18. doi: 10.1097/QAD.0000000000004095.
    PubMed     Abstract available


  118. ELF JL, Lebina L, Motlhaoleng K, Chon S, et al
    A randomized trial for combination nicotine replacement therapy for smoking cessation among people with HIV in a low-resourced setting.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004093.
    PubMed     Abstract available


  119. MIGAUD P, Pria AD, Hosmann K, Kellerher P, et al
    Hemophagocytic lymphohistiocytosis in HIV-associated HHV8-positive multicentric castleman disease.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004094.
    PubMed     Abstract available


  120. MATTHEWS LT, Bruxvoort KJ, Jaggernath M, Kriel Y, et al
    Use of tenofovir-based PrEP among pregnant women in South Africa.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004090.
    PubMed     Abstract available


  121. LIU B, Zhang Q
    Association between CD4 count, CD4/CD8 ratio, and fragility fractures in people living with HIV: a retrospective cohort study in China.
    AIDS. 2024 Dec 17. doi: 10.1097/QAD.0000000000004091.
    PubMed     Abstract available


  122. WANG C, Letendre SL, Hong S, Andalibi M, et al
    Differential systemic immune-inflammation index levels in people with and without HIV infection.
    AIDS. 2024 Dec 13. doi: 10.1097/QAD.0000000000004088.
    PubMed     Abstract available


  123. WANG T, Xu Y, Zhou S, Zhang X, et al
    Associations between salivary microbiota and KSHV infection in people with HIV: a cross-sectional study in ili prefecture, Xinjiang, China.
    AIDS. 2024 Dec 11. doi: 10.1097/QAD.0000000000004087.
    PubMed     Abstract available


  124. WEISSER M, Mapesi H, Vanobberghen F, Okuma J, et al
    Body weight changes in people living with HIV starting dolutegravir versus efavirenz-based regimens in a large cohort in rural Tanzania.
    AIDS. 2024 Dec 4. doi: 10.1097/QAD.0000000000004085.
    PubMed     Abstract available


  125. IRIARTE E, Smyth HL, Schmiege S, Tassiopoulos K, et al
    Predictors of frailty trajectories among people with HIV.
    AIDS. 2024 Dec 3. doi: 10.1097/QAD.0000000000004086.
    PubMed     Abstract available


  126. DREYER AJ, Le Roux C, Gf Thomas K, Sabin CA, et al
    Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV.
    AIDS. 2024 Dec 2. doi: 10.1097/QAD.0000000000004080.
    PubMed     Abstract available


  127. YEE LM, Powis KM, Jao J, Haddad LB, et al
    Substance use during pregnancy and postpartum among individuals with perinatally-acquired HIV in the United States.
    AIDS. 2024;38:2103-2107.
    PubMed     Abstract available


  128. BERING L, Heftdal LD, Heidari SL, Hamm SR, et al
    Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.
    AIDS. 2024;38:2100-2103.
    PubMed     Abstract available


  129. PARASKEVIS D, Masenga SK
    Self-collected or staff-collected dried blood spot specimens for HIV-1 viral load testing.
    AIDS. 2024;38:2098-2099.
    PubMed    


  130. SALVANA EMT, Martinez E
    Still losing sleep over HIV.
    AIDS. 2024;38:2096-2097.
    PubMed    


  131. BOLZENIUS J, Agan BK
    Mitigating cognitive impairment in people with HIV by targeting potential impacts of toxoplasmic infection.
    AIDS. 2024;38:2093-2095.
    PubMed    


  132. MAZZITELLI M, Trunfio M, Scaglione V, Sasset L, et al
    Multidimensional program for insomnia in a cohort of people with HIV.
    AIDS. 2024;38:2040-2049.
    PubMed     Abstract available


    November 2024
  133. LI W, Li G, Liu Y, Meng L, et al
    Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.
    AIDS. 2024 Nov 29. doi: 10.1097/QAD.0000000000004079.
    PubMed     Abstract available


  134. HE B, Chen S, Yang X, Olatosi B, et al
    Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina.
    AIDS. 2024 Nov 28. doi: 10.1097/QAD.0000000000004077.
    PubMed     Abstract available


  135. SUKUMARAN L, Sabin CA, Kunisaki KM, Doyle N, et al
    Associations between multimorbidity burden and objective and patient-reported sleep outcomes among people living with HIV.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004073.
    PubMed     Abstract available


  136. LESKO CR, Fojo AT, Hutton HE, Falade-Nwulia OO, et al
    The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic, 2012-2023.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004074.
    PubMed     Abstract available


  137. BAQUERO L, Stover S, Armani Tourret M, Perbelis A, et al
    Differential immunophenotype and proviral composition in young adults with perinatally acquired HIV: Are special cure strategies needed?
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004075.
    PubMed     Abstract available


  138. PAULSEN FW, Tetens MM, Gerstoft J, Kronborg G, et al
    Use of non-barrier contraceptives among women with human immunodeficiency virus; a nationwide, matched cohort study.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004067.
    PubMed     Abstract available


  139. BROMBERG DJ, Rhoades D, Madden LM, Ivasiy R, et al
    Transformation of the HIV treatment cascade for people who inject drugs in Ukraine.
    AIDS. 2024 Nov 26. doi: 10.1097/QAD.0000000000004056.
    PubMed     Abstract available


  140. GUPTA SK, Friedman AN, Desta Z
    The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysis.
    AIDS. 2024 Nov 25. doi: 10.1097/QAD.0000000000004071.
    PubMed     Abstract available


  141. PAPOT E, Tovar-Sanchez T, Woods J, Thaurignac G, et al
    SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa.
    AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068.
    PubMed     Abstract available


  142. FILIP I
    The case for integrating menopause care and HIV management.
    AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004069.
    PubMed    


  143. AUGELLO M, Bono V, Rovito R, Santoro A, et al
    Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.
    AIDS. 2024;38:1987-1990.
    PubMed     Abstract available


  144. LUISA MONTES M, Busca C, Rava M, Bernardino JI, et al
    Hepatic steatosis-insulin resistance and type 2 diabetes in people with HIV at diagnosis: effect of initial antiretroviral therapy.
    AIDS. 2024;38:1982-1987.
    PubMed     Abstract available


  145. SHERER R, Simon GL
    Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?
    AIDS. 2024;38:1980-1981.
    PubMed    


  146. MASENGA SK, Bernardino JI
    Binge eating correlates with weight excess in people with HIV.
    AIDS. 2024;38:1978-1979.
    PubMed    


  147. YAN LD, Rouzier V, Sufra R, Sauveur RST, et al
    Treatment of prehypertension among adults with HIV: a randomized clinical trial.
    AIDS. 2024 Nov 14. doi: 10.1097/QAD.0000000000004065.
    PubMed     Abstract available


  148. DOS SANTOS AP, Willig AL, Ruderman S, Oliveira VHF, et al
    Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study.
    AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004061.
    PubMed     Abstract available


  149. NOVITSKY V, Steingrimsson J, Guang A, Dunn CW, et al
    Dynamics of clustering rates in the rhode Island HIV-1 epidemic.
    AIDS. 2024 Nov 11. doi: 10.1097/QAD.0000000000004062.
    PubMed     Abstract available


  150. VONDER TW, Mudrikova T
    Higher non-HIV-comorbidity burden in long-term survivors.
    AIDS. 2024 Nov 6. doi: 10.1097/QAD.0000000000004054.
    PubMed     Abstract available


  151. FRIEDMAN MR, Wingood G, Krause KD, Krier S, et al
    Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort.
    AIDS. 2024 Nov 5. doi: 10.1097/QAD.0000000000004053.
    PubMed     Abstract available


  152. CUI Y, Moyo S, Pretorius Holme M, Hurwitz KE, et al
    Predictors of HIV seroconversion in Botswana: machine learning analysis in a representative, population-based HIV incidence cohort.
    AIDS. 2024 Nov 4. doi: 10.1097/QAD.0000000000004055.
    PubMed     Abstract available


  153. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
    Response to "Epicardial fat tissue and diastolic dysfunction in both men and women with HIV".
    AIDS. 2024;38:1895.
    PubMed    


  154. HAN WM, Apornpong T, Tumkosit M, Avihingsanon A, et al
    Epicardial fat tissue and diastolic dysfunction in both men and women with HIV.
    AIDS. 2024;38:1893-1894.
    PubMed    


  155. MUCCINI C, Gianotti N, Lolatto R, Nozza S, et al
    CD4+/CD8+ improvement after switch from a second-generation integrase inhibitor regimen to long-acting cabotegravir and rilpivirine.
    AIDS. 2024;38:1890-1892.
    PubMed     Abstract available


  156. MARTINEZ E, Dorfman D
    Addressing methamphetamine use in persons with HIV.
    AIDS. 2024;38:1888-1889.
    PubMed    


  157. GOODKIN K, Winston A, Martinez E, Paul R, et al
    Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognition.
    AIDS. 2024;38:1885-1887.
    PubMed    


    October 2024
  158. SUVADA K, Kocher E, Diwan N, Nagy A, et al
    Incidence of high blood pressure among Kenyan adults living with HIV: a longitudinal cohort analysis from 2004-2023.
    AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004050.
    PubMed     Abstract available


  159. VOLLMOND CV, Tetens MM, Gerstoft J, Kronborg G, et al
    Bipolar disorder in people with HIV: A nationwide, population-based matched case-control and matched cohort study.
    AIDS. 2024 Oct 29. doi: 10.1097/QAD.0000000000004049.
    PubMed     Abstract available


  160. ENI-OLUTU A, Mackie NE, Glenn J, Bailey A, et al
    Emerging integrase resistance in an international perinatal virtual clinic.
    AIDS. 2024 Oct 28. doi: 10.1097/QAD.0000000000004048.
    PubMed     Abstract available


  161. CHAISSON LH, Durovni B, Umar N, Cohn S, et al
    Sex differences in tuberculosis infection and disease among people with HIV.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004045.
    PubMed     Abstract available


  162. VERGORI A, Del Duca G, Lorenzini P, Brita AC, et al
    Impact of switching from EFV/F/TDF to B/F/TAF on psychiatric symptoms and neurocognition.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004043.
    PubMed     Abstract available


  163. RUDERMAN SA, Hunt PW, Beck-Engeser G, Ambayec G, et al
    Biomarkers of microbial translocation and generalized inflammation are associated with frailty among people with HIV.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004047.
    PubMed     Abstract available


  164. DUONG KNC, Schmutz HW, Ben-Umeh KC, Duru EE, et al
    Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis.
    AIDS. 2024 Oct 25. doi: 10.1097/QAD.0000000000004046.
    PubMed     Abstract available


  165. SOCIO GV, Ricci E, Piconi S, Squillace N, et al
    Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort.
    AIDS. 2024 Oct 22. doi: 10.1097/QAD.0000000000004042.
    PubMed     Abstract available


  166. OLIVERO R, Williams PL, Sawyer G, Yee LM, et al
    Birth outcomes following bictegravir exposure during pregnancy.
    AIDS. 2024 Oct 15. doi: 10.1097/QAD.0000000000004041.
    PubMed     Abstract available


  167. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
    The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.
    AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004038.
    PubMed     Abstract available


  168. RUBIN LH, Maki PM, Du Y, Sweeney SE, et al
    Imaging the translocator protein 18 kDa within cognitive control and declarative memory circuits in virally-suppressed people with HIV.
    AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004034.
    PubMed     Abstract available


  169. HEFFRON R, Muwonge TR, Thomas KK, Zewdie K, et al
    Bone density changes in young women in Uganda using tenofovir-based HIV pre-exposure prophylaxis and depot medroxyprogesterone acetate contraception.
    AIDS. 2024 Oct 9. doi: 10.1097/QAD.0000000000004029.
    PubMed     Abstract available


  170. HEY M, Thompson L, Portwood C, Sexton H, et al
    Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women living with HIV: a systematic review and meta-analysis.
    AIDS. 2024 Oct 8. doi: 10.1097/QAD.0000000000004032.
    PubMed     Abstract available


  171. FILIP I
    Person-centered pre-exposure prophylaxis: the next wave of innovation in HIV prevention.
    AIDS. 2024 Oct 7. doi: 10.1097/QAD.0000000000004030.
    PubMed    


  172. SIREGAR T, Weriditi RK, Reba YA, Muttaqin MZ, et al
    Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy.
    AIDS. 2024;38:1807-1808.
    PubMed    


  173. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
    Cancer in people with multidrug-resistant HIV.
    AIDS. 2024;38:1801-1806.
    PubMed     Abstract available


  174. LEAL M, Kerr L, Mota RMS, Motta-Castro ARC, et al
    Increasing HIV prevalence rate among men who have sex with men: results of a comparison of two national surveys.
    AIDS. 2024;38:1799-1801.
    PubMed     Abstract available


  175. GOUVEA-E-SILVA LF
    Challenges in clinical monitoring of people with HIV: evolution from prediabetes mellitus to diabetes mellitus.
    AIDS. 2024;38:1796-1798.
    PubMed    


  176. NICOL MR, Dawood H, Hoy JF
    Deconvoluting the contribution of antiretroviral choice in weight gain.
    AIDS. 2024;38:1794-1795.
    PubMed    


    September 2024
  177. WIJSTMA E, Jongen VW, Boyd A, de Vries HJC, et al
    Outcomes of a policy to prioritize populations with expected healthcare barriers for subsidized PrEP care in Amsterdam, the Netherlands: a cross-sectional study.
    AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004027.
    PubMed     Abstract available


  178. PASTORI D, Del Sole F, Brogi T, Del Ben M, et al
    Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease.
    AIDS. 2024 Sep 30. doi: 10.1097/QAD.0000000000004028.
    PubMed     Abstract available


  179. BROCHON J, Ducruet T, Taillefer S, Lamarre V, et al
    Increased risk of hospitalization among children who were HIV-exposed and uninfected compared to population controls.
    AIDS. 2024 Sep 27. doi: 10.1097/QAD.0000000000004025.
    PubMed     Abstract available


  180. REID MJA, Bunnell R, Davis M, Carter H, et al
    Sustaining two decades of PEPFAR's response to global HIV/AIDS: mitigating the impact of climate threats.
    AIDS. 2024 Sep 23. doi: 10.1097/QAD.0000000000004023.
    PubMed    


  181. LAM JO, Hou CE, Lee C, Samiezade-Yazd Z, et al
    Hypertension control and risk of age-associated dementia in people with hiv infection.
    AIDS. 2024 Sep 18. doi: 10.1097/QAD.0000000000004017.
    PubMed     Abstract available


  182. YADAV A, Gionet G, Karaj A, Kossenkov AV, et al
    Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on ART.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004015.
    PubMed     Abstract available


  183. UELAND T, Nkele I, Hoel H, Lockman S, et al
    Markers of extracellular matrix degradation and inflammasome activation are associated with carotid plaques in virally suppressed people with HIV in Botswana.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004014.
    PubMed     Abstract available


  184. FILIP I
    Twice-yearly lenacapavir may change the standard of HIV prevention for women.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004013.
    PubMed    


  185. OVERTON ET, Kantor A, Fitch KV, Mosepele M, et al
    Proteinuria and albuminuria among a global primary CVD prevention cohort of PWH: prevalence and associated factors.
    AIDS. 2024 Sep 16. doi: 10.1097/QAD.0000000000004016.
    PubMed     Abstract available


  186. SAHU M, Schaafsma T, Szpiro AA, Van Rooyen H, et al
    Performance of patient-collected dried blood spot specimens for HIV-1 viral load testing: evidence from the DO ART Study in South Africa.
    AIDS. 2024 Sep 13. doi: 10.1097/QAD.0000000000004011.
    PubMed     Abstract available


  187. KUNIHOLM MH, Murenzi G, Shumbusho F, Brazier E, et al
    Association of cardiovascular disease risk with liver steatosis and fibrosis in people living with hiv in low- and middle-income countries.
    AIDS. 2024 Sep 12. doi: 10.1097/QAD.0000000000004012.
    PubMed     Abstract available


  188. CUMMINGS TH, Magagnoli J, Sikirzhytskaya S, Tyagin I, et al
    Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among People Living with HIV.
    AIDS. 2024 Sep 10. doi: 10.1097/QAD.0000000000004009.
    PubMed     Abstract available


  189. ZANIEWSKI E, Skrivankova VW, Brazier E, Avihingsanon A, et al
    Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
    AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
    PubMed     Abstract available


  190. RUDERMAN SA, Willig AL, Cleveland JD, Burkholder G, et al
    Low food security is associated with frailty status and frailty components among people with HIV.
    AIDS. 2024 Sep 4. doi: 10.1097/QAD.0000000000004006.
    PubMed     Abstract available


  191. EUSTAQUIO PC, Burnett J, Prejean J, Chapin-Bardales J, et al
    Changes in HIV Pre-exposure Prophylaxis Awareness and Use Among Males Who Inject Drugs Who Have Sex with Men by Sexual Identity, 19 US Urban Areas, 2018 & 2022.
    AIDS. 2024 Sep 3. doi: 10.1097/QAD.0000000000004005.
    PubMed     Abstract available


  192. ZHAO R, Sanstead E, Alarid-Escudero F, Huchko M, et al
    Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
    AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004002.
    PubMed     Abstract available


  193. FILIP I
    Perinatal exposure to HIV leaves a lasting neurocognitive mark - even when vertical transmission is prevented.
    AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004004.
    PubMed    


  194. BURGER D, Wttewaal E, Oosterhof P, Stalenhoef J, et al
    Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
    AIDS. 2024;38:1728-1729.
    PubMed    


  195. PRYKE LA, Liu Z, Khaitan AK, Sims EK, et al
    Immune checkpoints and pancreatic beta cell dysfunction in HIV.
    AIDS. 2024;38:1725-1727.
    PubMed     Abstract available


  196. TREVILLYAN JM, Dart A, Paul E, Dewar EM, et al
    Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk.
    AIDS. 2024;38:1722-1724.
    PubMed     Abstract available


  197. MUCHAILI L, Masenga SK
    Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV.
    AIDS. 2024;38:1720-1721.
    PubMed    


    August 2024
  198. TARAMASSO L, Dentone C, Cama I, Fenoglio D, et al
    Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV.
    AIDS. 2024 Aug 30. doi: 10.1097/QAD.0000000000004001.
    PubMed     Abstract available


  199. NEARY J, Chebet D, Benki-Nugent S, Moraa H, et al
    Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
    AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000004000.
    PubMed     Abstract available


  200. CRAWFORD TN, Neilands TB, Drumright LN, Fredericksen RJ, et al
    Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.
    AIDS. 2024 Aug 29. doi: 10.1097/QAD.0000000000003999.
    PubMed     Abstract available


  201. HYBEL TE, Sorensen EF, Enemark MH, Hemmingsen JK, et al
    Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.
    AIDS. 2024 Aug 22. doi: 10.1097/QAD.0000000000003996.
    PubMed     Abstract available


  202. CAPELL-MORELL M, Bradbury M, Dinares MC, Hernandez J, et al
    Anal high-grade intraepithelial neoplasia and cancer in women living with HIV and HIV-negative women with other risk factors.
    AIDS. 2024 Aug 14. doi: 10.1097/QAD.0000000000003995.
    PubMed     Abstract available


  203. DIAZ MM, Mccutchan JA, Crescini M, Tang B, et al
    Longitudinal Study of Cognitive Function in People with HIV and Toxoplasmic Encephalitis or Latent toxoplasma Infection.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003992.
    PubMed     Abstract available


  204. SILVA MS, Torres TS, Coutinho C, Jalil EM, et al
    Mpox, sexually transmitted infections and combination prevention: insights from a major cohort in Rio de Janeiro, Brazil.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003991.
    PubMed     Abstract available


  205. FILIP I
    Uneven progress in reducing mortality in people with HIV underscores the need for interventions focused on vulnerable populations.
    AIDS. 2024 Aug 9. doi: 10.1097/QAD.0000000000003993.
    PubMed    


  206. PATEL PB, Prince DK, Bolenzius J, Chen P, et al
    Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV.
    AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003989.
    PubMed     Abstract available


  207. ALDREDGE A, Mehta CC, Lahiri CD, Schneider MF, et al
    Consequences of low-level viremia among women with HIV in the United States from 2003 - 2020.
    AIDS. 2024 Aug 7. doi: 10.1097/QAD.0000000000003990.
    PubMed     Abstract available


  208. ZEWDIE K, Muwonge T, Ssebuliba T, Bambia F, et al
    A point-of-care tenofovir urine test improves accuracy of self-reported PrEP adherence and increases condomless sex reporting among young women.
    AIDS. 2024 Aug 2. doi: 10.1097/QAD.0000000000003988.
    PubMed     Abstract available



  209. Initial antiretroviral therapy regimen and risk of heart failure: Erratum.
    AIDS. 2024;38:1608.
    PubMed    



  210. Dolutegravir-induced neural tube defects in mice are folate responsive: Erratum.
    AIDS. 2024;38:1607.
    PubMed    



  211. The association between anticholinergic/sedative burden and physical frailty in people aging with HIV: Erratum.
    AIDS. 2024;38:1606.
    PubMed    


  212. ELAHI S
    Galectin-9, a lingering shadow in HIV's fight: the unseen battle of adolescents with perinatally-acquired HIV.
    AIDS. 2024;38:1589-1591.
    PubMed    


  213. KOHLER P, Larsen A, Abuna F, Owiti G, et al
    Patient actor training improves preexposure prophylaxis delivery for adolescent girls and young women in Kenya: a cluster randomized trial.
    AIDS. 2024;38:1505-1512.
    PubMed     Abstract available


  214. ZALLA LC, Hutton HE, Fojo AT, Falade-Nwulia OO, et al
    The anxiety care continuum and its association with viral suppression among persons with HIV.
    AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003986.
    PubMed     Abstract available


  215. HURCHUND R, Sibiya SE, Owaga BO, Owira PMO, et al
    Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats.
    AIDS. 2024 Aug 1. doi: 10.1097/QAD.0000000000003987.
    PubMed     Abstract available


  216. BOZZI G, Centazzo M, Scaglioni S, Butta GM, et al
    Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics.
    AIDS. 2024;38:1601-1604.
    PubMed    


  217. CHAMBERS C, Cooper CL, Kroch AE, Buchan SA, et al
    Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves.
    AIDS. 2024;38:1597-1600.
    PubMed     Abstract available


  218. LINFIELD RY, Slusky DJG, Moskatel LS
    The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing.
    AIDS. 2024;38:1595-1597.
    PubMed     Abstract available


    July 2024
  219. MANJI KP, Muhihi A, Duggan CP, Alwy Al-Beity FM, et al
    Fetal, neonatal, and infant death among offspring of pregnant women living with HIV in Tanzania.
    AIDS. 2024 Jul 31. doi: 10.1097/QAD.0000000000003985.
    PubMed     Abstract available


  220. KAMPOURI E, Damas J, Kusejko K, Ledergerber B, et al
    Prevalence of HIV-related stigma among people with HIV in Switzerland: addressing the elephant in the room.
    AIDS. 2024 Jul 25. doi: 10.1097/QAD.0000000000003983.
    PubMed     Abstract available


  221. MANN SC, Tong W, Abraham AG, Palella F, et al
    The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study.
    AIDS. 2024 Jul 19. doi: 10.1097/QAD.0000000000003978.
    PubMed     Abstract available


  222. STONER MCD, Kelly NK, Gomez-Olive FX, Mall S, et al
    Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa: A HPTN 068 case cohort study.
    AIDS. 2024 Jul 18. doi: 10.1097/QAD.0000000000003981.
    PubMed     Abstract available


  223. DUFFY CR, Herlihy JM, Zulu E, Mwananyanda L, et al
    Preterm birth among women living with HIV: impact of preconception cART initiation.
    AIDS. 2024 Jul 17. doi: 10.1097/QAD.0000000000003979.
    PubMed     Abstract available


  224. TEJEDOR MT, Rial-Crestelo D, Diab L, de Lagarde M, et al
    Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV.
    AIDS. 2024;38:1446-1448.
    PubMed    


  225. CAMPBELL L, Barbini B, Cromarty B, Hamzah L, et al
    Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil.
    AIDS. 2024;38:1442-1445.
    PubMed     Abstract available


  226. JOHNSON AT, Ntloedibe T, Mendez Reyes JE, Matshaba MS, et al
    Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV.
    AIDS. 2024;38:1439-1442.
    PubMed     Abstract available


  227. MATHUR P, Ramadhani HO, Kaplan R, Stafford KA, et al
    Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV.
    AIDS. 2024;38:1437-1439.
    PubMed     Abstract available


  228. MATSENA-ZINGONI Z, Blower S
    Successful control of HIV in sub-Saharan Africa is causing a new problem.
    AIDS. 2024;38:1435-1436.
    PubMed    


  229. MAUSS S, Stapleton JT, Thomas DL
    Steatotic liver disease progression in persons with HIV: weighting for answers.
    AIDS. 2024;38:1432-1434.
    PubMed    


  230. HILL AM, Elbirt D
    Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial.
    AIDS. 2024;38:1430-1431.
    PubMed    


  231. YAN Y, Yuan R, Deng L, Hu H, et al
    The construction of a novel supplementary diagnostic model for patients with indeterminate HIV infection: a proteomics study.
    AIDS. 2024 Jul 15. doi: 10.1097/QAD.0000000000003977.
    PubMed     Abstract available


  232. BAMFORD L, Rajagopal A, Grelotti D, Justice-Royster V, et al
    Impact of methamphetamine use on HIV and other health outcomes at an urban HIV medicine clinic.
    AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003975.
    PubMed     Abstract available


  233. WILLIAMS LD, van Heerden A, Friedman SR, Chibi B, et al
    Comparison of a novel expanded social network recruitment intervention with risk network recruitment to HIV testing: locating undiagnosed cases in South Africa.
    AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003976.
    PubMed     Abstract available


  234. SILHOL R, Maheu-Giroux M, Soni N, Fotso AS, et al
    The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Cote d'Ivoire, Mali, and Senegal.
    AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003974.
    PubMed     Abstract available


  235. KING EM, Tkachuk S, Tseng A
    Aging on Antiretrovirals: Reviewing the need for pharmacologic data in elderly people living with HIV.
    AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003973.
    PubMed    



  236. Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum.
    AIDS. 2024;38:1280.
    PubMed    



  237. Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum.
    AIDS. 2024;38:1279.
    PubMed    


  238. DE S CARVALHO R, Rangel IC, Ferry FRA
    Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.
    AIDS. 2024;38:1275-1278.
    PubMed    


  239. TRUNFIO M, Bonora S, di Perri G, Calcagno A, et al
    Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV.
    AIDS. 2024;38:1273-1275.
    PubMed    


  240. KARABAY O
    Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
    AIDS. 2024;38:1273.
    PubMed    


  241. LEROY P, Diamantis S, Sellier PO, Hamet G, et al
    Prescriptions of generic antiretroviral drugs in three healthcare centers in the Paris area, France.
    AIDS. 2024;38:1269-1272.
    PubMed     Abstract available


  242. RUBENSTEIN E, Diemer M, Goldwirt L, Lascoux-Combe C, et al
    Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine.
    AIDS. 2024;38:1267-1269.
    PubMed     Abstract available


  243. ABDEL-HAMEED EA, Masenga SK
    HIV-related gut damage persists long-term in perinatally acquired HIV and is associated with insulin resistance.
    AIDS. 2024;38:1265-1266.
    PubMed    


  244. WINSLOW DL
    Is early initiation of antiretroviral therapy important?
    AIDS. 2024;38:1263-1264.
    PubMed    


  245. MOOLLA H, Davies MA, Davies C, Euvrard J, et al
    The effect of care interruptions on mortality in adults resuming antiretroviral therapy.
    AIDS. 2024;38:1198-1205.
    PubMed     Abstract available


    June 2024
  246. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
    Cervical cancer screening integrated in routine clinical care of women living with HIV.
    AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
    PubMed     Abstract available


  247. WU C, Xu X, Peng C, Lou Z, et al
    Cost-effectiveness of different intervention strategies of human immunodeficiency virus in Zhejiang, China: a Model Study From 2023 to 2052.
    AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003968.
    PubMed     Abstract available


  248. MASTERS MC, Tassiopoulos K, Bao Y, Wu K, et al
    Risk factors for progression from prediabetes to diabetes among older persons with HIV.
    AIDS. 2024 Jun 26. doi: 10.1097/QAD.0000000000003970.
    PubMed     Abstract available


  249. MARTINSON T, Montoya R, Moreira C, Kuncze K, et al
    Point-of-care urine tenofovir test predicts future HIV pre-exposure prophylaxis discontinuation among young users.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003962.
    PubMed     Abstract available


  250. KING JM, Dobbins T, Keen P, Cornelisse VJ, et al
    Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003961.
    PubMed     Abstract available


  251. YOTEBIENG M, Zotova N, Bernard C, Goodrich S, et al
    Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003963.
    PubMed     Abstract available


  252. MICHAEL HU, Brouillette MJ, Tamblyn R, Fellows LK, et al
    Cognitive impact of anticholinergic and sedative burden in people living with HIV.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003966.
    PubMed     Abstract available


  253. ROSE PC, Davies C, Cotton MF, Otwombe K, et al
    Longitudinal controlled attenuation parameter and liver stiffness in children with and without perinatal HIV infection in South Africa.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003964.
    PubMed     Abstract available


  254. SCHNITTMAN SR, Talathi R, Wilks MQ, Hedgire S, et al
    Association of T-cell subtypes with macrophage-specific arterial infiltration in PWH.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003967.
    PubMed     Abstract available


  255. RUSSO SC, Ockene MW, Arpante AK, Johnson JE, et al
    Efficacy and safety of tesamorelin in people with hiv on integrase inhibitors.
    AIDS. 2024 Jun 21. doi: 10.1097/QAD.0000000000003965.
    PubMed     Abstract available


  256. BLAIR J, Kempf MC, Dionne JA, Causey-Pruitt Z, et al
    Awareness, treatment, and control of hypertension among women at risk or living with HIV in the US South: a prospective study.
    AIDS. 2024 Jun 20. doi: 10.1097/QAD.0000000000003960.
    PubMed     Abstract available


  257. FILIP I
    Decoding the effects of statins on cardiovascular risk: are we closer to better risk-prediction tools for people with HIV?
    AIDS. 2024 Jun 19. doi: 10.1097/QAD.0000000000003958.
    PubMed    


  258. SODEKE O, Milligan K, Ezeuko I, Oladipo A, et al
    Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir.
    AIDS. 2024 Jun 13. doi: 10.1097/QAD.0000000000003956.
    PubMed     Abstract available


  259. FUNG K, Hernandez-Diaz S, Zash R, Chadwick EG, et al
    First-trimester exposure to newer antiretroviral agents and congenital anomalies in a U.S. cohort.
    AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003955.
    PubMed     Abstract available


  260. HWANG YJ, Lesko CR, Brown TT, Alexander GC, et al
    Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: a longitudinal cohort study.
    AIDS. 2024 Jun 12. doi: 10.1097/QAD.0000000000003954.
    PubMed     Abstract available


  261. MAZZITELLI M, Cozzolino C, Gasparini G, Chiaro E, et al
    Weight excess and obesity are associated with binge eating behaviours in people with HIV.
    AIDS. 2024 Jun 10. doi: 10.1097/QAD.0000000000003953.
    PubMed     Abstract available


  262. DRECHSLER H, Ayers C, Oboho I, Enwerem N, et al
    Choice of antiretroviral therapy has low impact on weight gain.
    AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003950.
    PubMed     Abstract available


  263. KUROSAWA S, Yoshimura Y, Takada Y, Yokota T, et al
    A predictive model for HIV-related lymphoma: a case series and literature review in Japan.
    AIDS. 2024 Jun 3. doi: 10.1097/QAD.0000000000003949.
    PubMed     Abstract available


  264. ALIBUDBUD R
    Navigating the intersection: minority stress, mental health, and HIV care in the Philippines.
    AIDS. 2024;38:1097-1099.
    PubMed    


  265. LEMOINE S, Bobo M, Hocqueloux L, Legac E, et al
    Dolutegravir-induced severe sideroblastic anemia.
    AIDS. 2024;38:1095-1097.
    PubMed    


  266. HARRINGTON J, McCrary AW, Nguyen M, Nyandiko W, et al
    Proteomics discovery in children and young adults with HIV identifies fibrosis, inflammatory, and immune biomarkers associated with myocardial impairment.
    AIDS. 2024;38:1090-1093.
    PubMed     Abstract available


  267. RAIFORD JL, Tie Y, Yuan XA, Byrd KK, et al
    Progress towards achieving national goals for improved quality of life among cis-gender Black women with HIV.
    AIDS. 2024;38:1087-1090.
    PubMed     Abstract available


  268. MEYER L, Schim van der Loeff MF
    Sexually transmitted infections in the preexposure prophylaxis era.
    AIDS. 2024;38:1085-1086.
    PubMed    


  269. VANCE DE, Brew BJ
    Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV.
    AIDS. 2024;38:1081-1083.
    PubMed    


  270. GOYAL R, Hotchkiss J, Gilman B, Klein PW, et al
    The health equity implications of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    AIDS. 2024;38:1025-1032.
    PubMed     Abstract available


    May 2024
  271. WASILWA A, Amadi E, Ramadhani HO, Lascko T, et al
    Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003945.
    PubMed     Abstract available


  272. ZHANG M, Dai G, Smith DL, Zacco E, et al
    Interferon signaling pathways are upregulated in people with hiv with abnormal pulmonary diffusing capacity (DLCO).
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003946.
    PubMed     Abstract available


  273. MCCABE L, Burns JE, Latifoltojar A, Post FA, et al
    MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003947.
    PubMed     Abstract available


  274. CHITLE P, Sheira LA, Katabaro E, Winters S, et al
    The Impact of Financial Incentives on Mental Health among Adults in HIV Care in Lake Zone, Tanzania: A Two-Arm Randomized Controlled Trial.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003948.
    PubMed     Abstract available


  275. ZHAO J, Zhou X, Qiu Y, Jia R, et al
    Characterization of the gut butyrate-producing bacteria and lipid metabolism in African green monkey as a natural host of SIV infection.
    AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003944.
    PubMed     Abstract available


  276. NJUGUNA C, Long L, Mistri P, Chetty-Makkan C, et al
    A randomised trial of "Fresh Start" text messaging to improve return to care in people living with HIV who missed appointments in South Africa.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003939.
    PubMed     Abstract available


  277. WAGNER TA, Tierney C, Huang S, Nichols S, et al
    Prevalence of detectable HIV-DNA and -RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003937.
    PubMed     Abstract available


  278. SMITH AC, Goulet JL, Vlahov D, Justice AC, et al
    Self-injurious unnatural death among Veterans with HIV: a nested case-control study.
    AIDS. 2024 May 29. doi: 10.1097/QAD.0000000000003940.
    PubMed     Abstract available


  279. JONGKEES MJ, Tan NH, Geers D, de Vries RD, et al
    Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003933.
    PubMed     Abstract available


  280. KAMITANI E, Mizuno Y, Khalil GM, Viguerie A, et al
    Improving HIV Pre-exposure Prophylaxis Uptake with Artificial Intelligence and Automation: A Systematic Review.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003935.
    PubMed     Abstract available


  281. GOLDBERG RL, Peterson TE, Haberlen SA, Witt MD, et al
    Associations between epicardial, visceral and subcutaneous adipose tissue with diastolic function in men with and without HIV.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003936.
    PubMed     Abstract available


  282. GUIGUES A, Gimenez S, Mettling C, Maurel D, et al
    The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 replication.
    AIDS. 2024 May 21. doi: 10.1097/QAD.0000000000003931.
    PubMed     Abstract available


  283. CHANDASANA H, Hayes S, Buchanan AM, Brothers C, et al
    Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatrics.
    AIDS. 2024 May 20. doi: 10.1097/QAD.0000000000003929.
    PubMed     Abstract available


  284. WEISER SD, Sheira LA, Weke E, Zakaras JM, et al
    An agricultural livelihood intervention is associated with reduced HIV stigma among people living with HIV.
    AIDS. 2024 May 16. doi: 10.1097/QAD.0000000000003928.
    PubMed     Abstract available


  285. MATTHEWS LT, Jaggernath M, Kriel Y, Smith PM, et al
    Oral PrEP uptake, adherence, and persistence during periconception periods among women in South Africa: an intervention study.
    AIDS. 2024 May 15. doi: 10.1097/QAD.0000000000003925.
    PubMed     Abstract available


  286. KELLY NK, Ranapurwala SI, Pence BW, Hightow-Weidman LB, et al
    The relationship between anti-LGBTQ+ legislation and HIV prevention among sexual and gender minoritized youth.
    AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003926.
    PubMed     Abstract available


  287. XIA Q, Edelstein ZR, Katz B, Bertolino D, et al
    Impact of HIV pre-exposure prophylaxis prescriptions on HIV diagnoses in New York city.
    AIDS. 2024 May 14. doi: 10.1097/QAD.0000000000003927.
    PubMed     Abstract available


  288. TRICKEY A, Zhang L, Rentsch CT, Pantazis N, et al
    Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies.
    AIDS. 2024 May 8. doi: 10.1097/QAD.0000000000003924.
    PubMed     Abstract available


  289. BAI F, Bono V, Borghi L, Bonazza F, et al
    Association between tight junction proteins and cognitive performance in untreated Persons living with HIV (PLWH).
    AIDS. 2024 May 3. doi: 10.1097/QAD.0000000000003923.
    PubMed     Abstract available



  290. Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV: Erratum.
    AIDS. 2024;38:935.
    PubMed    


  291. BLOT-COSSARD A, Merad Y, Bachelard A, Lebreton C, et al
    Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort.
    AIDS. 2024;38:929-931.
    PubMed     Abstract available


  292. BARR EA
    Vespers: A nursing origin story set in the dawn of the HIV pandemic.
    AIDS. 2024;38:925-927.
    PubMed    


  293. FEENEY ER, Boix V, Hsue PY
    Chronotropic incompetence in HIV infection.
    AIDS. 2024;38:921-923.
    PubMed    


  294. ABDEL-HAMEED EA, Overton ET
    What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?
    AIDS. 2024;38:917-919.
    PubMed    


  295. GOTTERT A, Malone S, Pulerwitz J
    The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa.
    AIDS. 2024;38:913-915.
    PubMed    


  296. OURSLER KK, Briggs BC, Lozano AJ, Harris NM, et al
    Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.
    AIDS. 2024;38:825-833.
    PubMed     Abstract available


  297. LI N, Zheng HY, He WQ, He XY, et al
    Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
    AIDS. 2024;38:803-812.
    PubMed     Abstract available


  298. JIANG J, Wang L, Li Q, Wang Y, et al
    HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
    AIDS. 2024;38:779-789.
    PubMed     Abstract available


  299. SALTO JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al
    Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
    AIDS. 2024;38:933-934.
    PubMed    


    April 2024
  300. BRICKMAN CE, Agnello M, Imam N, Camejo P, et al
    Distinct anal microbiome is correlated with anal cancer precursors in men who have sex with men living with HIV.
    AIDS. 2024 Apr 30. doi: 10.1097/QAD.0000000000003920.
    PubMed     Abstract available


  301. DERSEH NM, Agimas MC, Tesfie TK
    Risk score prediction for bacteriologically confirmed tuberculosis among HIV-infected adults on antiretroviral therapy in Ethiopia: prognostic model development.
    AIDS. 2024 Apr 25. doi: 10.1097/QAD.0000000000003917.
    PubMed     Abstract available


  302. FILIP I
    Liver health matters: targeting modifiable factors to reduce the risk of advanced liver disease in people with HIV.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003915.
    PubMed    


  303. SAURA-LAZARO A, Augusto O, Fernandez-Luis S, Lopez-Varela E, et al
    HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003913.
    PubMed     Abstract available


  304. ZHAO J, Dong Y, Clark E, Garcia JM, et al
    Risk and predictors of penile cancer in US Veterans with HIV.
    AIDS. 2024 Apr 23. doi: 10.1097/QAD.0000000000003914.
    PubMed     Abstract available


  305. KADIYALA GN, Telwatte S, Wedrychowski A, Janssens J, et al
    Differential susceptibility of cells infected with defective and intact HIV proviruses to killing by obatoclax and other small molecules.
    AIDS. 2024 Apr 16. doi: 10.1097/QAD.0000000000003908.
    PubMed     Abstract available


  306. MOAR P, Linn K, Premeaux TA, Bowler S, et al
    Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV.
    AIDS. 2024 Apr 12. doi: 10.1097/QAD.0000000000003907.
    PubMed     Abstract available


  307. FLORES JM, Moline T, Regan SD, Chen YT, et al
    Neighborhood violent crime exposure is associated with PrEP non-use among black sexually minoritized men and transgender women: A GPS Study.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003906.
    PubMed     Abstract available


  308. JANG Y, Kim T, Choi Y, Ahn KH, et al
    Association between obesity and cancer risk in HIV-infected Asians.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003904.
    PubMed     Abstract available


  309. OOSTERHOF P, Van Luin M, Brinkman K, Burger DM, et al
    Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003905.
    PubMed     Abstract available


  310. GUARALDI G, Milic J, Renzetti S, Motta F, et al
    The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV.
    AIDS. 2024 Apr 10. doi: 10.1097/QAD.0000000000003903.
    PubMed     Abstract available


  311. SABERIAN C, Lurain K, Hill LK, Marshall V, et al
    Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
    AIDS. 2024 Apr 2. doi: 10.1097/QAD.0000000000003897.
    PubMed     Abstract available



  312. Prevalence and incidence of stroke among people with HIV: Erratum.
    AIDS. 2024;38:777.
    PubMed    


  313. DE COCK KM, El-Sadr WM
    Authors' response to comment on 'Invisible, but not absent'.
    AIDS. 2024;38:774-775.
    PubMed    


  314. AMON JJ
    To end AIDS, human rights must remain at the center of the HIV response.
    AIDS. 2024;38:773-774.
    PubMed    


  315. FRESSE A, Massy N, Fournier D, Pinel S, et al
    Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
    AIDS. 2024;38:768-771.
    PubMed     Abstract available


  316. FRASER D, Holt M, Ong JJ, Bourne C, et al
    A proposal for a simplified measure of HIV preexposure prophylaxis prevention-effective adherence in self-report questionnaires.
    AIDS. 2024;38:765-767.
    PubMed     Abstract available


  317. GONZALEZ-SCARANO F, Napravnik S, Vance DE
    Frailty and HIV-associated neurocognitive disorder are only modestly associated.
    AIDS. 2024;38:757-759.
    PubMed    


  318. GOODREAU SM, Wohlfeiler DA, Bertrand T
    Bringing back condoms.
    AIDS. 2024;38:761-763.
    PubMed    


  319. WILKINSON L, Grimsrud A
    Enabling effective differentiated service delivery transitions for people on antiretroviral treatment.
    AIDS. 2024;38:615-622.
    PubMed    


    March 2024
  320. DIRAJLAL-FARGO S, Yu W, Jacobson DL, Mirza A, et al
    Gut permeability is associated with lower insulin sensitivity in youth living with perinatally-acquired HIV.
    AIDS. 2024 Mar 28. doi: 10.1097/QAD.0000000000003896.
    PubMed     Abstract available


  321. SULLIVAN EV, Zahr NM, Zhao Q, Pohl KM, et al
    Contributions of cerebral white matter hyperintensities, age, and pedal perception to postural sway in people living with HIV.
    AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003894.
    PubMed     Abstract available


  322. SCHNURE MC, Kasaie P, Dowdy DW, Genberg BL, et al
    Forecasting the effect of HIV-targeted interventions on the age distribution of people living with HIV: a case study from Kenya.
    AIDS. 2024 Mar 27. doi: 10.1097/QAD.0000000000003895.
    PubMed     Abstract available


  323. GIANELLA S, Anderson C, Chaillon A, Wells A, et al
    Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
    AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
    PubMed     Abstract available


  324. WIJSTMA ES, Jongen VW, Boyd A, van den Elshout M, et al
    Concordance between daily diary reported PrEP intake and intraerythrocytic tenofovir diphosphate (TFV-DP) in the Amsterdam PrEP demonstration project.
    AIDS. 2024 Mar 21. doi: 10.1097/QAD.0000000000003889.
    PubMed     Abstract available


  325. KEMP CG, Pence BW, Velloza J, Concepcion T, et al
    Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
    PubMed     Abstract available


  326. MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
    Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
    PubMed     Abstract available


  327. CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
    Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
    AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
    PubMed     Abstract available


  328. HAW NJL, Lesko CR, Ng DK, Lam J, et al
    Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
    AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
    PubMed     Abstract available


  329. HU FH, Tang XL, Ge MW, Jia YJ, et al
    Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
    AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
    PubMed     Abstract available


  330. HIMELHOCH SS, Shuter J
    Authors' response to 'Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment'.
    AIDS. 2024;38:614.
    PubMed    


  331. DAUNGSUPAWONG H, Wiwanitkit V
    Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV: comment.
    AIDS. 2024;38:613.
    PubMed    


  332. DICKSON S, James K
    Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance.
    AIDS. 2024;38:610-612.
    PubMed     Abstract available


  333. VANDERVEEN LA, Selzer L, Moldt B, Parvangada A, et al
    HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.
    AIDS. 2024;38:607-610.
    PubMed     Abstract available


  334. LEE D, Capeau J
    Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
    AIDS. 2024;38:603-605.
    PubMed    


  335. ZACCARELLI M
    Reassessing the emphasis on limited options in antiretroviral treatment.
    AIDS. 2024;38:599-601.
    PubMed    


  336. WINSTON A, Price P
    Could humoral immune responses to herpesviruses be a pathogenic driver of cognitive disorders in persons with HIV?
    AIDS. 2024;38:597-598.
    PubMed    


  337. MASCOLO S, Romanelli A
    A new frontier in HIV care: the predictive power of renal biomarkers on heart health.
    AIDS. 2024;38:595-596.
    PubMed    


  338. COLBRUNN DK, Jacks C, Curry SR, Gebregziabher M, et al
    Outcomes of discordant HIV screening test results at a southern academic medical center.
    AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003884.
    PubMed     Abstract available


  339. CROWELL TA, Ritz J, Zheng L, Naqvi A, et al
    Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
    AIDS. 2024 Mar 14. doi: 10.1097/QAD.0000000000003881.
    PubMed     Abstract available


  340. FILIP I
    Changing costs of pre-exposure prophylaxis may undermine efforts to curb HIV infection rates.
    AIDS. 2024 Mar 12. doi: 10.1097/QAD.0000000000003883.
    PubMed    


  341. DADABHAI S, Chou VB, Pinilla M, Chinula L, et al
    Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial.
    AIDS. 2024 Mar 4. doi: 10.1097/QAD.0000000000003878.
    PubMed     Abstract available


    February 2024
  342. SHIVAKOTI R, Giganti MJ, Lederman MM, Ketchum R, et al
    Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery.
    AIDS. 2024 Feb 26. doi: 10.1097/QAD.0000000000003877.
    PubMed     Abstract available


  343. WILSON IB, Cole MB, Lee Y, Shireman TI, et al
    The relationship of age and comorbid conditions to hospital and nursing home days in Medicaid recipients with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003870.
    PubMed     Abstract available


  344. WISEMAN RL, Bigos KL, Dastgheyb RM, Barker PB, et al
    Brain N-acetyl-aspartyl-glutamate (NAAG) is associated with cognitive function in older virally-suppressed people with HIV.
    AIDS. 2024 Feb 22. doi: 10.1097/QAD.0000000000003871.
    PubMed     Abstract available


  345. PATEL D, Beer L, Yuan X, Tie Y, et al
    Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men.
    AIDS. 2024 Feb 8. doi: 10.1097/QAD.0000000000003860.
    PubMed     Abstract available


    January 2024
  346. GEORGIADIS N, Papamichail D, Lytras T, Halkitis PN, et al
    The impact of HIV pre-exposure prophylaxis on bacterial sexually transmitted infection occurrence in MSM: A Systematic Review and Meta-analysis.
    AIDS. 2024 Jan 12. doi: 10.1097/QAD.0000000000003837.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.